What BBI Solutions does

BBI Solutions is a UK-headquartered manufacturer of raw materials, reagents, and contract manufacturing services for the in vitro diagnostics (IVD) and life sciences industries. Founded in 1955 and operating from Crumlin with regional offices in Germany, the United States, China, and South Africa, the company employs over 500 people across seven global facilities. Its product portfolio centers on critical assay components: native and recombinant enzymes (including horseradish peroxidase, where BBI claims the position of world's largest primary manufacturer powering more than 5 billion glucose strips annually), antibodies, antigens, gold colloid and gold conjugates (powering more than 400 million lateral flow tests per year), cell culture reagents such as Holo and Apo transferrin, and human serum controls.

The company's core technology is upstream biochemical manufacturing rather than software or instrumentation. Production capabilities include up to 5,000-liter batch purification, gold nanoparticles with coefficient of variation of 8% or less, and over 600 custom gold conjugations per year, all operated under ISO 13485-certified quality systems with a supply resilience framework that includes inventory coverage and secondary sourcing for strategic products. Beyond catalog reagent sales, BBI operates a meaningful contract manufacturing business spanning antibody development and production, lateral flow device assembly from pilot to multi-million-unit runs, custom gold conjugation, and protein customization with fermentation fine-tuning.

BBI's commercial model is B2B sales-led, targeting IVD manufacturers and life sciences companies through direct enterprise sales, regional offices, an e-commerce storefront, and event marketing at industry conferences such as ADLM and ADA. Pricing is quotation-based, reflecting the customized nature of reagent supply and contract manufacturing agreements. The company is privately held under Baduhenna Topco Limited, has executed multiple acquisitions (including IBEX Technologies for $37.9 million in April 2024), and most recently announced a strategic partnership with Lateral Dx in December 2025 to integrate assay development with manufacturing scale.

Name

BBI Solutions

Legal name

Baduhenna Topco Limited

Website

https://bbisolutions.com

Company type

Private

Founded year

1986

Operating status

Operating

Headcount range

251–500 employees

Short description

BBI Solutions manufactures IVD raw materials and contract manufacturing services — enzymes, antibodies, antigens, gold conjugates, and lateral flow components — for diagnostic OEMs and life sciences companies across five continents.

Ownership category

akta.pro rank

Product category

In Vitro Diagnostics (IVD) Reagents

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

akta.pro secondary industries

Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL), Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering) (HLAAAIAB), Blood Bank, Transfusion Medicine & Immunohematology (HLAHAAAH)

Keywords

• IVD reagents
• Diagnostic enzymes
• Gold nanoparticles
• Lateral flow assays
• Antibody manufacturing

Headquarters

HQ city

Crumlin

HQ country

United Kingdom

HQ region

Europe

Offices5 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Reagent Product Sales: Sale of native and recombinant reagents including enzymes, antibodies, antigens, gold colloid, gold conjugates, cell culture reagents, stabilizers, blockers, and substrates to IVD manufacturers
2. Contract Manufacturing Services: ISO 13485-certified manufacturing services including antibody production, lateral flow contract manufacture, and custom gold conjugation
3. Custom Development: Tailored reagent customization including bespoke antigens, high-activity enzymes, protein customization, and custom conjugations

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

BBI Solutions manufactures and supplies native and recombinant reagents for the in vitro diagnostics industry, including enzymes (notably Horseradish Peroxidase), antibodies, antigens, gold colloid, gold conjugates, cell culture reagents, human serum and control materials, immuno-affinity columns, polystreptavidin, stabilizers/blockers/substrates, and ELISA kits. The company complements its catalog with ISO 13485-certified contract manufacturing services covering antibody development and production, lateral flow device assembly, custom gold conjugation, and protein customization for diagnostic test developers.

Product overview

BBI Solutions is a provider of world-class reagents and IVD manufacturing services for the diagnostics and life sciences industries. The product portfolio centers on critical raw materials for diagnostic assay development: native and recombinant enzymes (including HRP, where BBI is the world's largest primary manufacturer powering over 5 billion annual glucose strips), antibodies and antigens across clinical areas (autoimmune, cardiac, infectious disease, diabetes, hormones, tumor markers), gold colloid and gold conjugates for lateral flow detection (powering 400+ million annual tests), cell culture reagents including transferrin products, and human serum control materials. The company complements its reagent catalog with contract manufacturing services including antibody development and production, lateral flow contract manufacture, custom gold conjugation (600+ annually), and protein customization. The portfolio is organized as catalog reagents plus customization services, supporting customers from discovery through commercial-scale production under ISO 13485 certification.

Differentiator

Problem solved

Functional benefit

Products and services

• Enzymes Enzymes used as critical reagents in diagnostic testing, including Horseradish Peroxidase (HRP) where BBI is the world's largest primary manufacturer. Enzymes support applications such as glucose monitoring and lateral flow tests for IVD manufacturers.
• Antibodies Antibodies for diagnostic assay development, including secondary antibodies and controls, used in IVD applications across autoimmune, inflammation, cardiac, and infectious diseases clinical areas.
• Gold Colloid Gold colloid nanoparticles used as detection reagents in lateral flow diagnostics, with BBI's gold colloid powering over 400 million lateral flow tests annually.
• Gold Conjugates Gold conjugate reagents linking antibodies, antigens, or oligos to ultra-uniform gold nanoparticles (≤8% CV) for lateral flow assay detection, with custom conjugation services available.
• Antigens Antigens used as capture and detection reagents in immunoassays, covering clinical areas including infectious disease, tumor markers, hormones, and autoimmune conditions.
• Cell Culture Reagents Cell culture reagents including Holo and Apo transferrin products manufactured under ISO 13485 certification from FDA-licensed plasma, used to accelerate cell growth in serum-free cultures.
• Human Serum & Control Materials Human serum and control materials used as reference standards and quality controls in diagnostic assay development and manufacturing.
• Stabilizers, Blockers, & Substrates Stabilizers, blockers, and substrates used to optimize assay performance, improve shelf-life, and enhance detection sensitivity in diagnostic tests.
• Immuno-affinity Columns (IAC) Immuno-affinity columns (IAC) for sample purification and analyte isolation in diagnostic testing workflows.
• Polystreptavidin Polystreptavidin reagents for enhanced binding in diagnostic assays, particularly useful in lateral flow and ELISA applications.
• ELISA Kits ELISA kits for human diagnostic applications, covering autoimmune, infectious disease, and allergy testing.
• Transferrin (Holo & Apo) Transferrin products including iron-saturated Holo transferrin (near 100% saturation) and iron-poor Apo transferrin (near zero iron), produced in 5 kg ISO 13485 lots from FDA-screened plasma with heat pasteurization to WHO guidelines, for serum-free cell culture applications.
• Antibody Development Goal-driven antibody development services including antigen mapping, hybridoma generation, and purified discovery antibody delivery within tight timelines, with rigorous screening and subcloning for IVD manufacturers.
• Antibody Manufacturing Antibody production scaling up to 5g using roller-bottle or hollow-fibre bioreactors, with purification, polishing, conjugation, and characterization services under ISO 13485 certification.
• Lateral Flow Contract Manufacture ISO 13485-certified lateral flow contract manufacturing including automated striping, laminating, cutting, and assembly of test devices from pilot lots to multi-million unit production runs.
• Custom Gold Conjugation Custom gold conjugation services performing over 600 custom conjugations annually, linking antibodies, antigens, or oligos to ultra-uniform nanoparticles (≤8% CV) and scaling batches to 24L at OD10.
• Protein Customization Protein customization services including gene screening, fermentation fine-tuning from pilot to production scale (up to 5,000L batches), and purification for bespoke antigens and high-activity enzymes.

Quantifiable outcome

• 5bn+ annual glucose strips powered by BBI enzymes
• +4 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Lateral DxcoreStrategic or Co-development Partner · 18 December 2025Strategic partnership combining Lateral Dx's advanced assay development capabilities with BBI's ISO 13485-certified scalable manufacturing infrastructure. Enables customers to move from concept to commercial-scale production with reduced development timelines. Lateral Dx leads assay design and optimization; BBI provides end-to-end manufacturing and regulatory support from Crumlin facilities.

Scale indicators8 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Abcam: Major supplier of antibodies and reagents for research and diagnostic applications. Closely comparable to BBI's antibody and reagent catalog serving diagnostic assay developers, with similar B2B commercial model.
• Sekisui Diagnostics: Provider of clinical chemistry reagents, coagulation, and immunoassay components to IVD manufacturers. Direct overlap with BBI's clinical chemistry and immunoassay reagent business for the same diagnostic OEM customers.
• Meridian Bioscience (Revvity): A leading manufacturer of diagnostic raw materials including antigens, antibodies, and reagents for IVD manufacturers. Directly comparable to BBI's core reagent catalog and lateral flow components business, serving the same IVD customer base.
• Surmodics: Provider of IVD reagents and surface coatings for diagnostic test manufacturers. Comparable to BBI in serving IVD developers with critical reagents and immunoassay components, particularly in lateral flow and clinical chemistry.

Broad incumbents

• Cytiva (Danaher): Global provider of bioprocessing and life sciences reagents including cell culture media and diagnostics components. Comparable to BBI in cell culture reagents (transferrin) and broader diagnostic raw materials supply.
• Thermo Fisher Scientific: Largest life sciences tools company, supplying enzymes, antibodies, and IVD raw materials. Competes broadly with BBI across reagent categories while also bundling instruments, consumables, and services.
• Bio-Techne: Diversified life sciences tools company offering antibodies, proteins, ELISA kits, and reagents. Overlaps with BBI's antibody, antigen, and diagnostic reagent portfolio while operating at much greater scale across multiple end markets.
• Merck KGaA / MilliporeSigma: Global life sciences tools and reagents giant offering antibodies, enzymes, and assay components. Competes with BBI across catalog reagent categories while also serving broader research and bioprocessing markets.

Emerging players

• GenScript: Biotechnology company offering gene synthesis, protein production, and antibody development services. Comparable to BBI's antibody development and protein customization services for diagnostics and research customers.
• Fapon Biotech: Asian-headquartered IVD raw materials supplier offering antigens, antibodies, and enzymes for diagnostic manufacturers. Increasingly competitive with BBI in gold conjugates and lateral flow components, particularly in APAC markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/bbinternational
• Xx.com/bbi_solutions
• Facebookfacebook.com/BBISolutions

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BBI Solutions